Le Lézard
Classified in: Health
Subjects: NPT, CSR, DIS

May Institute Expert Offers Advice to Help Adults with Special Needs Who Also Have Dementia


September is Dementia Awareness Month

RANDOLPH, Mass., Sept. 26, 2023 /PRNewswire/ -- According to the National Institutes of Health, dementia is the most feared condition for people over 65 and the second most feared condition, after cancer, among younger adults.

This fear is understandable. Imagine waking up scared and confused because you do not know where you are, suddenly forgetting steps in daily routines, and struggling to remember what someone just said.

"Now, imagine all that happening to an adult with an intellectual or developmental disability," says Dr. Jenna Gilder, Director of Clinical Services and Training for May Institute's Adult Services. "Studies show that individuals with intellectual/developmental disability (IDD) are just as much at risk for developing dementia as the general population. Individuals with Down syndrome are approximately five times more at risk for developing Alzheimer's disease than the general population ? and at an earlier age."

A national leader in providing evidence-based services for individuals across the lifespan with autism and other developmental disabilities, May Institute also serves a large number of adults with IDD.

"Although new research and support strategies are being published in the dementia field, little is out there for individuals with a dual diagnosis of IDD and dementia," says Dr. Gilder, who is also a Regional Trainer for the National Task Group on Intellectual Disabilities and Dementia Practices (NTG). "The NTG and other organizations are focusing on ways to help this underserved population."

If an adult with IDD starts to demonstrate dementia symptoms such as memory loss, confusion, challenges with language, and poor judgment, the NTG recommends that caregivers complete the NTG-Early Detection Screen for Dementia and give it to their doctor.

"This is not a diagnostic assessment, but rather a screening tool that should be done every year starting at age 40 for individuals with IDD, even if dementia symptoms are not present," Dr Gilder explains. "It will provide a baseline that can be compared with later screenings if symptoms develop. This screening tool is also beneficial because some dementia symptoms commonly seen in individuals with IDD differ from those usually seen in the typical population. As a result, misdiagnosis can occur.

"By using NTG-recommended tools and support strategies at May Institute, we are helping individuals with IDD and symptoms of dementia lead the safest, happiest, and most fulfilling lives possible," Dr. Gilder adds.

These practical strategies include:

For more helpful strategies and resources, visit the NTG website.

Jenna Gilder, Ph.D., BCBA, LABA is May Institute's Director of Clinical Services and Training for Adult Services and is a Regional Trainer for the National Task Group on Intellectual Disabilities and Dementia Practices (NTG).

May Institute is a nonprofit organization that is a national leader in the field of applied behavior analysis, serving individuals with autism spectrum disorder and other developmental disabilities, brain injury and neurobehavioral disorders, and other special needs. Founded more than 65 years ago, we provide a wide range of exceptional educational and rehabilitative services across the lifespan. For more information, call 800.778.7601 or visit www.mayinstitute.org.

SOURCE May Institute


These press releases may also interest you

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 07:00
Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on TERLIVAZ® (terlipressin) for injection in patients with hepatorenal syndrome (HRS) with rapid reduction in kidney function1 at the 2024...

17 mai 2024
Family Braces, Calgary's largest group of orthodontists with five locations across the city, reports a strong start to the second quarter of 2024. This positive momentum builds on the group's successful first quarter, underlining its...

17 mai 2024
American Skin Association (ASA) announced the recipients of the 2024 Inaugural Founders Award and the 2024 Research Achievement Awards at the 2024 Society for Investigative Dermatology (SID) Annual Meeting. ...

17 mai 2024
The Honourable Seamus O'Regan Jr., Minister of Labour and Seniors, on behalf of the Honourable Mark Holland, Canada's Minister of Health, and the Honourable Tom Osborne, Newfoundland and Labrador's Minister of Health and Community Services will make...



News published on and distributed by: